Published in Int J Clin Exp Pathol on April 20, 2008
DNA hypomethylation in cancer cells. Epigenomics (2009) 3.71
Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker. Int J Clin Exp Pathol (2010) 1.24
Piwil2 expressed in various stages of cervical neoplasia is a potential complementary marker for p16. Am J Transl Res (2010) 1.13
Association of the promoter methylation and protein expression of Fragile Histidine Triad (FHIT) gene with the progression of differentiated thyroid carcinoma. Int J Clin Exp Pathol (2010) 0.87
5-aza-2'-deoxycytidine leads to reduced embryo implantation and reduced expression of DNA methyltransferases and essential endometrial genes. PLoS One (2012) 0.87
Expression and significance of Musashi-1 in gastric cancer and precancerous lesions. World J Gastroenterol (2013) 0.85
Correlation between the germline methylation status in ERβ promoter and the risk in prostate cancer: a prospective study. Fam Cancer (2016) 0.78
Case-control study of candidate gene methylation and adenomatous polyp formation. Int J Colorectal Dis (2016) 0.75
Reduced 5-methylcytosine level as a potential progression predictor in patients with T1 or non-invasive urothelial carcinoma. Int J Mol Sci (2014) 0.75
Association of estrogen receptor α gene PvuII and XbaI polymorphisms with non-small cell lung cancer. Oncol Lett (2011) 0.75
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
The fundamental role of epigenetic events in cancer. Nat Rev Genet (2002) 30.05
Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med (2003) 18.04
Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res (1998) 8.95
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet (1994) 8.34
Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med (2006) 7.62
Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res (2005) 6.49
Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med (2004) 5.65
MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst (2005) 5.22
Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol (2004) 5.12
DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol (2005) 5.02
Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet (2001) 3.96
Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res (1988) 3.22
Histone deacetylases: unique players in shaping the epigenetic histone code. Ann N Y Acad Sci (2003) 3.05
Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review). Oncol Rep (2005) 2.96
Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Clin Cancer Res (2006) 2.70
Emerging concepts in colorectal neoplasia. Gastroenterology (2002) 2.44
Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet (2002) 2.43
Epigenetic changes in colorectal cancer. Cancer Metastasis Rev (2004) 2.35
BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res (2003) 2.27
The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res (2000) 1.96
Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res (2000) 1.88
Methylation and colorectal cancer. J Pathol (2001) 1.61
COX-2 inhibition and colorectal cancer. Semin Oncol (2004) 1.53
Hyperplastic polyps and colorectal cancer: is there a link? Clin Gastroenterol Hepatol (2004) 1.50
Colorectal cancer: a multipathway disease. Crit Rev Oncog (2006) 1.48
DNA methylation, field effects, and colorectal cancer. J Natl Cancer Inst (2005) 1.44
Hypomethylation: one side of a larger picture. Ann N Y Acad Sci (2003) 1.44
Cancer stem cells: the lessons from pre-cancerous stem cells. J Cell Mol Med (2007) 1.38
DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Br J Cancer (2006) 1.36
Precancerous stem cells have the potential for both benign and malignant differentiation. PLoS One (2007) 1.36
Human estrogen receptor-alpha: regulation by synthesis, modification and degradation. Cell Mol Life Sci (2002) 1.27
Epigenetics in carcinogenesis and cancer prevention. Ann N Y Acad Sci (2003) 1.26
Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut (2006) 1.25
Risk of invasive carcinoma in colorectal adenomas assessed by size and site. Int J Colorectal Dis (1997) 1.21
Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats. Cancer Res (2006) 1.19
Delay in diagnosis of colorectal cancer in elderly patients. Age Ageing (1993) 1.14
Invasive carcinoma in colorectal adenomas: multivariate analysis of patient and adenoma characteristics. Endoscopy (1997) 1.14
Precancerous stem cells can serve as tumor vasculogenic progenitors. PLoS One (2008) 1.14
Estrogen and colon cancer: current issues. Climacteric (2002) 1.01
Pathogenesis of colorectal cancer. Surg Clin North Am (2002) 0.99
Colon polyps and cancer. Endoscopy (2003) 0.93
Enzymatic regional methylation assay: a novel method to quantify regional CpG methylation density. Genome Res (2002) 0.92
Modulation by celecoxib and difluoromethylornithine of the methylation of DNA and the estrogen receptor-alpha gene in rat colon tumors. Carcinogenesis (2004) 0.87
Chemoprevention of colorectal cancer. Dis Colon Rectum (2006) 0.86
Methylation of the ESR1 CpG island in the colorectal mucosa is an 'all or nothing' process in healthy human colon, and is accelerated by dietary folate supplementation in the mouse. Biochem Soc Trans (2005) 0.83
Celecoxib as adjunctive therapy for treatment of colorectal cancer. Ann Pharmacother (2001) 0.81
Modulation of DNA hypomethylation as a surrogate endpoint biomarker for chemoprevention of colon cancer. Mol Carcinog (2004) 0.80
Celecoxib shown effective in preventing colon polyps. J Natl Cancer Inst (2006) 0.80
CpG island methylation and histone modifications: biology and clinical significance. Ernst Schering Res Found Workshop (2006) 0.80
Chemoprophylaxis of colon cancer. Curr Gastroenterol Rep (2005) 0.79
Enzymatic regional methylation assay for determination of CpG methylation density. Anal Chem (2004) 0.78
Cyclooxygenase-2 as target for chemopreventive interventions: new approaches. Cancer Biomark (2007) 0.77
Foxp3 controls autoreactive T cell activation through transcriptional regulation of early growth response genes and E3 ubiquitin ligase genes, independently of thymic selection. Clin Immunol (2006) 0.77
MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell (2010) 2.59
A novel 3D mammalian cell perfusion-culture system in microfluidic channels. Lab Chip (2007) 2.03
Influence of inspiration to expiration ratio on cyclic recruitment and derecruitment of atelectasis in a saline lavage model of acute respiratory distress syndrome. Crit Care Med (2015) 1.95
Precancerous stem cells have the potential for both benign and malignant differentiation. PLoS One (2007) 1.36
Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker. Int J Clin Exp Pathol (2010) 1.24
Identification of Piwil2-like (PL2L) proteins that promote tumorigenesis. PLoS One (2010) 1.17
Precancerous stem cells can serve as tumor vasculogenic progenitors. PLoS One (2008) 1.14
Piwil2 expressed in various stages of cervical neoplasia is a potential complementary marker for p16. Am J Transl Res (2010) 1.13
Modulation of genetic and epigenetic biomarkers of colorectal cancer in humans by black raspberries: a phase I pilot study. Clin Cancer Res (2010) 1.12
Nonlinear optical microscopy: use of second harmonic generation and two-photon microscopy for automated quantitative liver fibrosis studies. J Biomed Opt (2009) 1.07
Fibro-C-Index: comprehensive, morphology-based quantification of liver fibrosis using second harmonic generation and two-photon microscopy. J Biomed Opt (2009) 1.06
Prevention of mouse lung tumors by budesonide and its modulation of biomarkers. Carcinogenesis (2002) 1.03
ERalpha suppresses slug expression directly by transcriptional repression. Biochem J (2008) 1.03
Invasive micropapillary carcinoma of the sigmoid colon: distinct morphology and aggressive behavior. Int J Clin Exp Pathol (2008) 0.93
Perfusion culture improves the maintenance of cultured liver tissue slices. Tissue Eng (2007) 0.92
Overcoming the limitation of phase retrieval using Gerchberg-Saxton-like algorithm in optical fiber time-stretch systems. Opt Lett (2015) 0.92
Expression of EphA2 and E-cadherin in gastric cancer: correlated with tumor progression and lymphogenous metastasis. Pathol Oncol Res (2009) 0.92
Inhibition of expression of the chromatin remodeling gene, SNF2L, selectively leads to DNA damage, growth inhibition, and cancer cell death. Mol Cancer Res (2009) 0.91
Design and synthesis of a gossypol derivative with improved antitumor activities. Arch Pharm (Weinheim) (2009) 0.91
B7-CD28 interaction promotes proliferation and survival but suppresses differentiation of CD4-CD8- T cells in the thymus. J Immunol (2004) 0.91
Germline stem cell gene PIWIL2 mediates DNA repair through relaxation of chromatin. PLoS One (2011) 0.90
Clinical outcomes in extracranial tumor sites and unusual toxicities with concurrent whole brain radiation (WBRT) and Erlotinib treatment in patients with non-small cell lung cancer (NSCLC) with brain metastasis. Lung Cancer (2010) 0.90
Deficient activation and resistance to activation-induced apoptosis of CD8+ T cells is associated with defective peripheral tolerance in nonobese diabetic mice. Clin Immunol (2003) 0.89
Antitumor activity of G3139 lipid nanoparticles (LNPs). Mol Pharm (2009) 0.88
DNA hypomethylation induced by non-genotoxic carcinogens in mouse and rat colon. Cancer Lett (2004) 0.88
Natural killer dendritic cells are an intermediate of developing dendritic cells. J Leukoc Biol (2007) 0.88
Association of the promoter methylation and protein expression of Fragile Histidine Triad (FHIT) gene with the progression of differentiated thyroid carcinoma. Int J Clin Exp Pathol (2010) 0.87
Breathing laser as an inertia-free swept source for high-quality ultrafast optical bioimaging. Opt Lett (2014) 0.87
Modulation by celecoxib and difluoromethylornithine of the methylation of DNA and the estrogen receptor-alpha gene in rat colon tumors. Carcinogenesis (2004) 0.87
Prognostic factors of distal cholangiocarcinoma after curative surgery: a series of 84 cases. Hepatogastroenterology (2014) 0.86
Establishment and characterization of a human telomerase catalytic subunit-transduced fetal bone marrow-derived osteoblastic cell line. Differentiation (2007) 0.85
CD28/B7-mediated co-stimulation is critical for early control of murine cytomegalovirus infection. Viral Immunol (2009) 0.85
Antibody response to inactivated influenza A (H1N1) 2009 monovalent vaccine in patients with and without HIV. J Acquir Immune Defic Syndr (2011) 0.84
Overexpression of MMSET is correlation with poor prognosis in hepatocellular carcinoma. Pathol Oncol Res (2012) 0.83
3D hepatocyte monolayer on hybrid RGD/galactose substratum. Biomaterials (2006) 0.83
FTY720 (Gilenya) phosphate selectivity of sphingosine 1-phosphate receptor subtype 1 (S1P1) G protein-coupled receptor requires motifs in intracellular loop 1 and transmembrane domain 2. J Biol Chem (2011) 0.83
Expression of a mutant p53 results in an age-related demographic shift in spontaneous lung tumor formation in transgenic mice. PLoS One (2009) 0.83
Spectrally-resolved statistical characterization of seeded supercontinuum suppression using optical time-stretch. Opt Express (2014) 0.82
Vitreous cryopreservation of cell-biomaterial constructs involving encapsulated hepatocytes. Tissue Eng (2007) 0.82
Broadband fiber-optical parametric amplification for ultrafast time-stretch imaging at 1.0 μm. Opt Lett (2014) 0.82
The CUSUM analysis of the learning curve for endoscopic thyroidectomy by the breast approach. Surg Innov (2013) 0.81
Modulation by budesonide of DNA methylation and mRNA expression in mouse lung tumors. Int J Cancer (2007) 0.81
Diagnosis and management of severe acute pancreatitis complicated with abdominal compartment syndrome. J Huazhong Univ Sci Technolog Med Sci (2003) 0.81
Modulation by bexarotene of mRNA expression of genes in mouse lung tumors. Mol Carcinog (2008) 0.81
Cell-delivery therapeutics for liver regeneration. Adv Drug Deliv Rev (2010) 0.81
Retracted Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (Zarnestra MT). Carcinogenesis (2006) 0.81
A Disintegrin and Metalloprotease with Thrombospondin Motif 2 May Contribute to Cirrhosis in Humans through the Transforming Growth Factor-β/SMAD Pathway. Gut Liver (2013) 0.79
Resonant radiation in synchronously pumped passive Kerr cavities. Opt Lett (2015) 0.79
Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma. Ann Clin Lab Sci (2010) 0.79
Prevention by methionine of dichloroacetic acid-induced liver cancer and DNA hypomethylation in mice. Toxicol Sci (2003) 0.78
A functional and protein-protein interaction analysis of neuroepithelial cell transforming gene 1 in hepatocellular carcinoma. Tumour Biol (2014) 0.78
Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (ZarnestraMT). Carcinogenesis (2006) 0.77
Vemurafenib in leptomeningeal carcinomatosis from melanoma: a case report of near-complete response and prolonged survival. Melanoma Res (2016) 0.77
Foxp3 controls autoreactive T cell activation through transcriptional regulation of early growth response genes and E3 ubiquitin ligase genes, independently of thymic selection. Clin Immunol (2006) 0.77
Modulation by budesonide of a CpG endonuclease in mouse lung tumors. Carcinogenesis (2007) 0.77
Effect of peroxisome proliferators on the methylation and protein level of the c-myc protooncogene in B6C3F1 mice liver. J Biochem Mol Toxicol (2002) 0.76
Singular v dual inhibition of SNF2L and its isoform, SNF2LT, have similar effects on DNA damage but opposite effects on the DNA damage response, cancer cell growth arrest and apoptosis. Oncotarget (2012) 0.76
Improved hepatocyte excretory function by immediate presentation of polarity cues. Tissue Eng (2006) 0.76
Diagnostic and surgical therapeutic features of extrahepatic bile duct carcinoma without jaundice. World J Gastroenterol (2004) 0.75
1000-1400-nm partially mode-locked pulse from a simple all-fiber cavity. Opt Lett (2015) 0.75
Experimental observation of the spontaneous breaking of the time-reversal symmetry in a synchronously pumped passive Kerr resonator. Opt Lett (2014) 0.75
[Inducement and proliferation of MSCs in vitro and preliminary study on interface between MSCs and metal materials]. Hua Xi Kou Qiang Yi Xue Za Zhi (2005) 0.75
A unique and as yet unexplored subset of metastatic colorectal cancer: widespread lymph-node-only recurrence. J Gastrointest Cancer (2013) 0.75
Real-time observation of round-trip resolved spectral dynamics in a stabilized fs fiber laser. Opt Express (2017) 0.75
Expression of inducible nitric oxide synthase in the liver is under the control of nuclear factor kappa B in concanavalin A-induced hepatitis. J Gastroenterol Hepatol (2007) 0.75
Generation of a mouse monoclonal antibody recognizing both the native and denatured forms of human VEGF. Hybridoma (Larchmt) (2009) 0.75
[Longitudinal observation of epidemic dynamics of schistosomiasis in bovine in two mountainous endemic regions]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi (2012) 0.75
[Expression of ADAMTS-2 and TGF-β1 in cirrhotic liver]. Zhong Nan Da Xue Xue Bao Yi Xue Ban (2012) 0.75
Early to intermediate steps of tumor embolic formation involve specific proteolytic processing of E-cadherin regulated by Rab7. Mol Cancer Res (2012) 0.75